Author

Scott McKenney

OpenAlex ID: A5081775288

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

2023 · John H Strickler, Andrea Cercek, et al. · The Lancet Oncology · 255

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

2025 · Hani M. Babiker, Vincent Picozzi, et al. · Journal of Clinical Oncology · 48

Works count: 2

Citation count: 303

H-index: 2

I10-index: 2